Why Clarity on Terminology Matters

Regulatory authorities such as the USFDA, EMA, ICH, and WHO define and apply these terms differently depending on whether the product is an API, intermediate, or finished dosage form. Using the wrong term—or placing the wrong date on a label—can result in:

• ❌ GMP observations or 483s
• ❌ Labeling recalls
• ❌ Misinterpretation of product stability and patient safety risk

Understanding these terms isn’t just academic—it’s central to regulatory compliance.

Official Definitions (ICH & WHO)

• Retest Date: The date after which a drug substance must be re-examined to verify it still meets specifications, if stored under recommended conditions (typically used for APIs).
• Expiry Date: The final date at which a drug product is expected to remain within specification and be safe and effective for use.
• Shelf Life: The total time period during which a product is expected to remain stable under specified conditions. It ends at the expiry or retest date.

These definitions are found in ICH Q1A(R2), WHO TRS 1010, and national regulatory guidelines.

Comparison Table of Key Differences

Labeling Implications and Compliance

The labeling of expiry and retest dates must comply with country-specific requirements:

• ✅ API containers must show retest date and batch number
• ✅ Finished goods must show expiry date in DD/MM/YYYY or MM/YYYY format
• ✅ Shelf life is usually included in stability data or dossier, not on physical labels

Use of incorrect date terminology on product labels has been cited in several recalls and GMP compliance observations.

Stability Testing Alignment

When generating stability data, it’s important to design studies to support each of these terms as appropriate:

• Retest Date: Include long-term and accelerated stability of APIs per ICH Q1A
• Expiry Date: Conduct full stability testing on final packaged dosage forms
• Shelf Life: Justified through trend analysis, can extend to expiry/retest date

Be cautious when converting between these terms during CTD submissions or regulatory renewals.

Where Each Term Appears in Regulatory Submissions

Common Misconceptions and Pitfalls

• ❌ Using “shelf life” on packaging instead of “expiry date”
• ❌ Applying retest dates to finished dosage forms
• ❌ Extending expiry dates without new stability data
• ❌ Ignoring regulatory variations (e.g., WHO vs ICH vs CDSCO)

Always cross-verify labeling SOPs with global dossier language and marketing country requirements.

Practical Case Scenario

A company manufacturing a bulk API labeled its material with an expiry date rather than a retest date. During a WHO PQP inspection, this was flagged as a labeling non-compliance. The company had to relabel over 40 drums of stock and update their SOPs. The issue could have been avoided by aligning their documentation with WHO’s recommendation of “retest date” for APIs.

Checklist for Teams

• ✅ Define each term clearly in SOPs and training programs
• ✅ Label APIs with retest dates and finished products with expiry dates
• ✅ Use shelf life only in internal stability and submission documents
• ✅ Align terminology in ERP, COA, and CTD
• ✅ Consult Regulatory Affairs before changing label format

For templates and SOPs, refer to SOP writing in pharma.

Conclusion

Understanding the distinctions between retest date, expiry date, and shelf life is essential for every pharmaceutical professional involved in product development, regulatory affairs, labeling, and QA. While these terms are interconnected, they are not interchangeable. Misapplication can result in regulatory action, product withdrawal, and loss of credibility.

By aligning your company’s terminology with ICH, WHO, and local guidelines—and implementing clear labeling and SOP practices—you can ensure compliance and reduce the risk of deviation or inspection findings.

References:

• ICH Q1A(R2), Q7
• WHO TRS 1010
• CDSCO Labeling Guidelines
• EMA Expiry Definitions

Why Global Consistency in Expiry Terminology Matters

Multinational pharmaceutical companies often market the same product across various regions. However, expiry-related terms may differ in meaning between jurisdictions:

• ❌ “Retest date” may be accepted in one region and rejected in another
• ❌ Shelf life vs. expiry might be used interchangeably, causing confusion
• ❌ Inconsistent use of terms across dossiers can result in questions during review

To harmonize these differences, the ICH and WHO have developed structured guidance.

ICH Interpretation of Expiry Terminology

The International Council for Harmonisation (ICH) provides guidance primarily through ICH Q1A(R2), Q1B, and Q7. Key definitions include:

• Shelf Life: The time period during which a drug product is expected to remain within approved specifications, stored under defined conditions.
• Expiry Date: The date placed on the label designating the time during which the product is expected to remain stable.
• Retest Date: The date by which an API should be re-examined to ensure it is still suitable for use.

Key Point: ICH encourages using “retest date” for APIs and “expiry date” for finished products, as detailed in ICH Q7.

WHO Interpretation of Expiry Terminology

The World Health Organization (WHO), through its stability and prequalification guidelines, aligns closely with ICH definitions but adds clarity in global health contexts.

According to WHO:

• Expiry Date: The date after which the product is not guaranteed to remain within specifications and should not be used.
• Retest Date: For APIs, the date beyond which testing is required prior to further use, provided storage is under defined conditions.
• Labeling Requirements: WHO explicitly requires clear indication of expiry or retest date depending on material type and regulatory filing.

WHO also emphasizes expiry control as a GMP principle, especially for medicines supplied through procurement programs.

Case Comparison: API Labeling for Retest vs Expiry

Consider a bulk API manufactured in India and exported to the EU and Africa. The same material may be labeled as follows:

• ✅ For EU (ICH territory): “Retest date: MM/YYYY”
• ✅ For WHO procurement: “Expiry date: MM/YYYY” based on receiving country’s guideline

This dual terminology must be addressed in regulatory documentation, quality agreements, and COAs.

For guidance on aligning terminology in SOPs, see Pharma SOPs best practices.

Common Challenges with Expiry Terminology

• ❌ Labeling APIs with both expiry and retest dates inconsistently
• ❌ Not updating ERP master data to reflect ICH-compliant terms
• ❌ Misinterpreting WHO’s requirement as mandatory expiry for all materials
• ❌ Using “shelf life” in documents without defining it clearly

Each of these can be addressed through cross-functional training and regulatory review.

Best Practices for Aligning with ICH and WHO

Here’s a checklist to align expiry terminology across your systems:

• ✅ Define “shelf life”, “retest date”, and “expiry date” in all SOPs
• ✅ Align ERP and labeling logic with ICH Q1A and Q7 terminology
• ✅ Use retest dates for APIs unless local regulation demands expiry
• ✅ Avoid using “shelf life” alone—tie it to a defined specification or condition
• ✅ Train Regulatory Affairs and QA on WHO vs. ICH interpretations

These steps help ensure consistency across labeling, submission documents, and inspection responses.

Integration in Dossiers and CTDs

In Common Technical Documents (CTDs), expiry and shelf life terms appear in Module 3 (Quality), particularly in sections:

• 3.2.P.8 – Stability Summary and Conclusion
• 3.2.S.7 – Stability of APIs
• Labeling section for Module 1 (country-specific)

Ensure terminology matches across modules and appendices to prevent delay in approvals.

Impact on Labeling and Packaging Control

Both WHO and ICH require clear labeling of expiry or retest dates on all containers:

• ✅ Finished Products: “Expiry date” is mandatory
• ✅ APIs: “Retest date” may be used unless national regulation states otherwise
• ✅ Secondary packaging must display the date clearly and be resistant to smearing or abrasion

Reconciliation of expiry labeling must be part of QA release procedures. For guidance, review GMP guidelines.

Table: Summary of Differences

Conclusion

Clear understanding and consistent application of expiry terminology—as defined by ICH and WHO—are vital for regulatory success, global compliance, and patient safety. While both organizations offer aligned guidance, their emphasis and context can vary depending on the type of product and country of sale.

Pharma professionals should ensure SOPs, ERP systems, submission documents, and labels reflect harmonized terminology, supported by sound stability data and regulatory knowledge.

References:

• ICH Q1A(R2), Q1B, Q7
• WHO Technical Report Series: Stability Guidelines
• CDSCO Expiry Labeling Rules
• USFDA Labeling and Expiry FAQs